Molecule Details
| InChIKey | TXSXJYRAIUVBDO-NLDSVXPCSA-N |
|---|---|
| Compound Name | (3S)-3-[[(2S)-3-amino-2-benzyl-3-oxopropanoyl]amino]-4-[[(2S)-1-[[(2S)-3-(1H-indol-3-yl)-1-[[[(2S)-2-[[(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-(4-sulfooxyphenyl)propanoyl]amino]hexanoyl]amino]methylamino]-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-oxobutanoic acid |
| Canonical SMILES | CCCC[C@H](NC(=O)[C@H](Cc1ccc(OS(=O)(=O)O)cc1)NC(=O)OC(C)(C)C)C(=O)NCNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](Cc1ccccc1)C(N)=O |
| Clinical Status | Clinical Multi-Target |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 6.0 |
| Source | ChEMBL;TTD_MultiTarget |
2D Structure
Activity Profile